Valirx Share Discussion Threads

[ben gibbons] 02/6/2023 15:19

WooooowWhat a very astute comment.I said a while back if 201 was that good then big pharma would be over it like a cheap suit.Very telling and this comment hits the nail on the head.Being strung along because 201 is a blank.Borsaci06Posts: 997Price: 9.25No OpinionCommercial ?Today 14:06Imho Except Delaware company No interest from established pharma indicates VAL series peptide have no commercial value in their eyes. Ceo/Bod know this and hanging on to TheoremRx as last chance for VAL series. If Valirx peptide/repurposed compound classed as oil/ gas show in exploration company, it would have been declared as non-commercial by now. Those willing to ditch TheoremRx & replace Ceo / Bod have not come up with better proposal, deal ...... for Val201. New additions to pipeline & lab will determine the faith of this company, rest is history. Spin in a spin for last 17 years got company almost nowhere, but speculating/manipulating/pumping/dumping investors got good return for their investment. More hopium will be the end result of changing Ceo/Bod. Put your better proposal, offer ...... for Val201 to Ceo/Bod and rest of the investors here. Did you arrange/find buyer for Val201 or will you, if changes happened at company? Show us the money

[porky9] 02/6/2023 14:51

@JasonPugh
Makes FA difference, only:-

1. What they actually deliver (Jam tomorrow dead)
2. How many headway shares they need ready to issue
3. If still pushing on with acquisition before 30/6 and is Buy and Build still on

Are they going to give Adam a NED position to save own asses and give him a massive share option to cover dilution at placing OR are they going to press on without him, do the placing and Adam then go hostile later to get elected to sort the BOD out.

I’m 50/50 preservation first, the bod won’t want to rock the boat pre re-election but equally they need headway shares....... will be interesting

[jasonpugh] 02/6/2023 14:33

@porky. You need to read the full government response. I only quoted a very small section. Not only speed of trials…much much more. Please read. 🫣

[porky9] 02/6/2023 14:06

Not an issue with the speed of setting up trials, its the speed of finding someone to pay for them especially in the current climate.

Obviously all eyes will be on the presentation on the 14th that is the main event when they discuss forward plans and if Buy and Build remains, the amount of headroom shares they need, any acquisitions if planned and the forward position from the H2.

Meanwhile we do have the results statement, due on Monday 5th. That should at least confirm that cash burn didn't exceed the projections. The headline figures we are expecting to the year end Dec 22 (so already 6 mths out of date) are:-

REVENUE £ 0 (2022) £ 0 (2021)
EBITDA -£ 1,471,000 (2022) -£ 1,264,000 (2021)
PBT -£ 2,313,000 (2022) -£ 1,681,000 (2021)
Net Cash £ 1,386,000 (2022) £ 594,000 (2021)

The thing here is that extra Jan raise after the year end only gave them £1.3m gross, not sure what the costs were. Lab fixtures were est £350k, other Lab costs £250k they have three extra staff, 11 now v 9 that will come out of that.

Admin costs forecast to increase in this 23 year by 27% from £1,230,000 to £ 1,518,000 in this year,

I think what i'm most surprised about is that when Kevin came on board April 21 he was really proud of the fact that he had got costs under control following the restructure. (Gerry still remained) but he had capital raise and had significantly slashed costs and the following year Suzy continued that ethos working to keep costs to an absolute minimum.

Now we find that the cost base is back up again to where it was pre crash. I just cant see the logic in this, its like business as usual. Guess its just been too easy to get cash during the biotech funding boom. Now its a different landscape.

Anyhow, next couple of weeks will be critical here IMO. I'm really interested if the proposed acquisition pre 30/6 will still happen, buy and build and headroom allocation - maybe im wrong but i just find it strange that VAL are increasing overheads with the lab etc at a time when the rest of the sector are battening down the hatches and preserving cash.

It will bee interesting how this unfolds. Good luck

[jasonpugh] 02/6/2023 11:50

Para 5 of the government’s response to above. “We are therefore delighted that lord o’shaughnessy has undertaken a detailed review of the uks commercial clinical trials ….we welcome all of lord o’shaughnessys recommendations̷0; and as a first step will work to deliver 5 upfront commitments backed by £121 million These commitments will make approving and setting up trials quicker …”. Read on for more. DYOR. 👍

[jasonpugh] 02/6/2023 11:18

Lord O’shaughnessy lead independent review into UK clinical trials on may 25th.
Hugh positive ramifications for valirx forthcoming. Look up on Gov.UK. DYOR

[jasonpugh] 01/6/2023 15:36

Would appear that stella panu actually does buy shares 🫣. Look at Vianet group plc (VNET)2nd Aug 2022 rns Director buys. Blimey gov she bought some you know. Wonder why shes not buying valirx at mo? Lol 🚀👇

[porky9] 01/6/2023 09:59

Reply to chief pumper on LSE before it’s deleted:

@PM2022

Oh your post really did make me chuckle, you genuinely believe it, is it to convince yourself?

Let me illustrate:-

1. You say Headroom shares are required but doesn’t mean they will use them.

REPLY: You are having a laugh. Giving VAL headroom shares and expecting they won’t use them is akin to Asking a Donkey to mind Strawberries.

15 Share issues, Three 125:1 Consolidations and 5 placings under Suzy with 6th to land

2. Everyone here knows we are massively undervalued due to the delays with 201 and the Buy and Build Policy

REPLY: Yes in this echo chamber of a forum you all keep telling yourselves that. From an analytical perspective, it’s massively overvalued due to the multiple issues but moreover, we are now in a biotech funding drought, the share price is doing incredibly well for some holders.

3. And it doesn’t even factor in CLX which is worth at least 20p

REPLY: No it’s not, it’s not worth £20m at this point. They need VAL to find a partner to fund phase trials to see if it works in this current climate. When they do it’s likely to be a milestone based deal with zero or minimal upfront due to how expensive these trials now are. It will take a lot of time. But cash in now short term is unlikely. 201 our Crown Jewels was given to a start up in the expectation of £1.3m down and that after two years still can’t complete. Market conditions for funding currently remain dire.

4. Cash until late 2024 and lots of news due

REPLY: Now you really are stretching it, 7 months cash runway from this H2 is the position. hence why they will ask anytime soon for headway shares. No event can bring cash in short term hence essential SH back the request. As for news, it’s going to take time, they can only update when they have something to say

Frankly your ramping gets worse by the day

[porky9] 31/5/2023 18:05

@JasonPugh
Above post pure 100% speculation
The reason why i thought PYC initially is because VAL reference a "technical acquisition" in the profile section of the CENKOS report in addition to "lab acquisitions" and i found that really interesting. It meets PYC profile and they work with them.
However recently, VAL put out that collaborative RNS so not sure if that is the extent of the relationship or they will want to extend it further?
Interesting that PYC share price crashed hence makes the deal more in reach?
Anyhow, will know soon enough. Don't think you can draw that much from Jim's reply.
Pork's

[jasonpugh] 31/5/2023 14:14

Just received email from physiomics ceo dr jim millen. “Is there any truth in the rumour that valirx are intending to buy out your company?”
Answer” physiomics is committed to remain a growing company. With todays rns this remains the case”
Interesting 🧐. 🫣

[412069] 31/5/2023 13:31

Porks will be gone soon enough once news put him 100% DDDD wrong yet again

[wulber] 31/5/2023 07:41

Porky, you were Mr VAL super ramper not long ago and now Mr VAL super deramper as your agenda changes, trying to suck people in, but unfortunately you over egg it and people find you annoying.With your relentless posts you need to know that less is more. I personally find BB's are 99% tripe and occasionally you get a golden nugget of info.

[jasonpugh] 31/5/2023 06:48

@porky. You are relentless though. I don’t understand why you keep repeating yourself.
So so many posts..and some very long… do you realise that if you posted less often and didn’t repeat elements within them you would 1. Get a bigger audience
2. Spend more time on other pursuits like family ties. Investment in other companies. Etc. just a thought. See you got one like from your apprentice

[porky9] 30/5/2023 23:29

@JasonPugh
Do you actually genuinely believe that the forum is balanced?
Because i don't.
What i see on numerous boards and this isn't exclusive to VALs board is a set group of posters that like to form an echo chamber of pure ramping content and any view outside of that is shot down without consideration.

Today, during numerous exchanges a poster asked a genuine question about the funding of phase trials. I replied to this poster from my research notes about the high cost to get drugs to market what the average price of each phase trial, i explained why THX would find it difficult to secure financial backing and i gave five links to white papers and editorial content where i referenced the information.

My post was not debated, they just claimed i didn't know what i was talking about and had the post removed. If a few posters click on the report button the post is auto removed they don't hand check it.

Later where chief ramper PM2022 was going on about how VAL were going to benefit from R&D Tax credits which would further extend the runway. I pointed out it was a mere 200k, less than a months cash burn- he wasn't having any of it and called me a liar.

I then copied page 11 of the CeNKOS report financial and detailed all the financials over the last five years and proved the point. Did he apologise, err No. He further argued i still didn't know what i was talking about despite the figures in black and white

So my point is they dont want to debate anything unless its fits with the s ramping agendas. But as i say this isnt exclusive to VAL - many other forums are the same

Pork's
Forget whats times i post about, i have international contacts i chat to. but i can still be a postman if that wors better for you

[jasonpugh] 30/5/2023 22:43

Porky. Read my last post please.22:34.

[jasonpugh] 30/5/2023 08:22

My issue is not with porky. Its with lse and advfn. I know porky is a premium member of lse and he has payed for this privilege but i request the moderator of these chats to look at the obvious repeated distress this particular avatar is causing by his relentless early morning repetitive posts. I appeal to lse and advfn to do something about this. Im all for a balanced view but come on. This is ridiculous .. in the interest of a fine balanced forum. Kindest regards Jason

[jasonpugh] 29/5/2023 22:03

Agree wulber. When i see porky post i just scroll down. Unless someone else comments on something he says that is important (very vera rare)🫣

[wulber] 29/5/2023 18:10

Yes, must be a good post by Wallcrawler as Porky can't stop posting here and on LSE, LOL.PS l've stopped reading his posts altogether now - silence is golden!

[porky9] 29/5/2023 12:08

Time for Suzy to go HardballToday 11:34

I have now realised as being an active part of this forum that despite pointing out where mistakes have been made and contributing ideas to correct them, that there is actually an underbelly of posters here that don’t seek long term value and want to support VAL to make a difference they are just here to ramp the back end out of it for quick gains. They buy penny shares on the AIM and constantly email and hassle Suzy with stupid emails demanding updates without consideration of the wider market issues the business faces nor that its a business not personal.

Further, shareholders thinking they were clever voted against resolution 4 handicapping the business from having the headway shares they need to give them the liquidity they need and meet the business plan objectives. Talk about shooting yourselves in the foot.

So if I was Suzy I would just go hardball with the lot of you:-

1. I would line up the deal with Jim at PYC give their shareholders a reasonable premium 2 PYC for 1 VAL - that would add 50m Shares but instantly add a) £660k revenue and b) Give Labs an exclusive USP and 3) cross fertilisation of contacts and clients 4) significant cost saving synergies having one listing rather than two - no brainer.

2. I would crack on with it and try and secure support for a placing at 5p if not 4p whatever price to secure support in this biotech funding drought. If she can get support at 5p I would line up to issue 40m Placing Shares at 5p and 10m shares at 5p to existing shareholders. That would raise £2.3m after costs and give them 18mths runway from H2 combined with PYC to take the market on with a better positioned group.

Oh I can hear you cry already, but no Porky, we wouldn’t support it, we can say no, Chuck our toys out the pram, stamp feet, we own the business, there will be no placing, no additions boo hoo hoo, you are posting lies, business should be, could be, might be, if be, fifty quid a share not 5p - well I have news for you. It’s business, the BOD need to do what it takes to survive in this climate. And could sort that issue in one phone call:

Ring, Ring,” Adam here” “Hi Adam it’s Suzy, long time no speak, look we need to get get this business better positioned, Jim can join from PYC and I think we can get the business advanced but don’t have the cash runway, Stella thinks we really need 24 mths from H2 but we could probably work with 18mths, only issue is Turner Pope think it’s going to be really difficult to raise in this climate but they have some clients that might support at 5p what do you think Adam” “ not sure Suzy that would increase shares in issue to 200m and dilute me by nearly 50%” “Well look Adam,I understand but if we secure your support we can complete this, what about you joining us as NED?, We get the deal done and we grant you say 5m Shares as joining fees and a further 10m as options at 7p and that would more than cover your dilution and the business is better placed”

[jasonpugh] 29/5/2023 11:49

Brilliant post by thewallcrawler on lse.👌